Finally … Some long-term functional outcomes data on first-line treatment

An article in this week’s New England Journal of Medicine offers us 15-year functional outcomes data from the Prostate Cancer Outcomes Study (PCOS), which enrolled 3,533 men in whom prostate cancer was diagnosed in 1994 or 1995. … READ MORE …

MRI-guided focused ultrasound in focal treatment of low-risk, localized prostate cancer

In October last year, the US Food and Drug Administration approved the ExAblate MRI-guided focused ultrasound technology for the treatment of pain associated with cancer metastasis to bones, which is obviously a potential benefit for men with late stage, metastatic prostate cancer. … READ MORE …

Age, hair loss, and risk for prostate cancer diagnosis

An excellent commentary on the NHS Choices web site addresses an article by an Australian research team showing that men who show signs of baldness by age 40 are at heightened risk for a diagnosis of prostate cancer, but that this is not the case at older ages. The risk of having prostate cancer at > 76 years old was about 15 percent in this study, regardless of hair loss at 40. … READ MORE …

Risk for biochemical failure post-surgery among prostate cancer patients > 70 years of age

A new article from the clinical research group at The Cleveland Clinic has suggested that men > 70 years of age are at significantly higher risk for recurrence of their prostate cancer if treated by radical prostatectomy than younger men with comparable diagnostic criteria. … READ MORE …

Of cow’s milk, doughnuts, fried chicken, and other important food groups

Two recent articles have linked certain dietary habits to risk for development of prostate cancer. The degree to which one feels that these dietary habits may be “proven” to increase risk for prostate cancer is probably going to be debatable; the existence of a potential link is certainly clear. … READ MORE …

Immediate, adjuvant ADT after surgery does not significantly affect survival of high-risk men

For many years, physicians at the Mayo Clinic in Rochester, MN, have been offering immediate, adjuvant androgen deprivation therapy (ADT) to some of their surgical patients with more advanced and high-risk forms of prostate cancer. The assumption had been that early use of ADT among such patients might have a significant survival benefit. … READ MORE …

Diagnosis of prostate cancer in UK projected to be more common

According to a report in today’s Daily Telegraph, Cancer UK is projecting a significant increase in risk for a diagnosis of prostate cancer in the United Kingdom over the next 50 to 60 years. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,153 other followers